Introduction {#s1}
============

Hearing impairment (HI) is a disabling congenital disease ([@B41]), with the highest rate for age-standardized disability of life in the world ([@B39]; [@B51]). Globally, congenital HI has a prevalence of 1.3 per 1,000 population ([@B24]) and accounts for about 1 per 1,000 live births in developed countries, with a much higher up to 6 per 1,000 in sub-Saharan Africa ([@B43]). To improve the cognitive, social, speech, and language development of children living with HI, early diagnosis and intervention are recommended ([@B3]). But in the absence of the widely used new-born screening, the age at diagnosis is usually late in Africa, e.g. 3.3 years in Cameroon ([@B56]). In many populations, nearly half of congenital HI cases have a genetic etiology, of which 70% are non-syndromic ([@B2]; [@B49]). Among non-syndromic (NS) HI, nearly 80% of the cases are inherited in autosomal recessive (AR) mode ([@B58]; [@B60]). To date, more than 98 genes have been identified, in ∼170 NSHI loci mapped (Hereditary Hearing Loss Homepage; <http://hereditaryhearingloss.org/>). Nevertheless, in many populations of European and Asian descent, pathogenic variants in *GJB2* (connexin 26 gene) and *GJB6* are major contributors to autosomal recessive NSHI (ARNSHI) ([@B8]), with the *GJB6*-D13S1830 deletion identified in up to 9.7%, as the second biggest genetic etiology of NS deafness in the European populations ([@B15]; [@B14]).

The prevalence of *GJB2*- or *GJB6*-related NSHI is very low in most sub-Saharan African populations ([@B18]; [@B27]; [@B5]; [@B25]; [@B31]). Of interest, previous studies have shown that a common founder mutation accounted for about 16.2% of congenital HI was p.R143W in a random sample of Ghanaians affected by hearing loss ([@B20]). To our knowledge, the contribution of connexin 30 to HI, and the carrier frequency of the *GJB2* mutation in non-affected individuals has not been studied in Ghana ([@B1]). In the present research, we aimed to investigate the putative environmental causes of childhood HI, and revisit the contribution of *GJB2*, and to investigate *GJB6* mutations in carefully selected samples of families segregating HI, and in isolated cases of putative genetic origin, as well control populations non-affected by HI, in Ghana.

Methods {#s2}
=======

Patient Participants {#s2_1}
--------------------

Hearing impaired patients were recruited from 11 schools for the deaf following procedures reported previously in Cameroon ([@B56]). Briefly, individuals with severe HI diagnosed before 15 years of age were enrolled in this study. For all participants, detailed personal and family history were obtained, and the medical records reviewed by a medical geneticist and an ENT specialist, and relevant data extracted, including three-generation pedigree and perinatal history. If required, a general systemic and otological examination and audiological evaluation were performed, including pure tone audiometry or auditory brain stem response test. We followed the recommendation number 02/1 of the *Bureau International d'Audiophonologie (BIAP*), Belgium, to classify the hearing levels ([@B7]; [@B56]). After consultation with the medical geneticist, individuals with syndromic deafness underwent additional assessment, when possible. As previously reported ([@B56]), HI was defined as: 1) acquired when associated with a putative environmental factor such a clinical evidence of meningitis; 2) genetic when at least two cases were reported in the same family without obvious environmental cause, in case of consanguinity, in case of presence of dysmorphism or developmental problems in addition to HI, or in case of a well-defined syndrome in clinically suspected; 3) of unknown etiology if either an environmental or a genetic origin were not clearly established.

Control Participants {#s2_2}
--------------------

A total of 145 control participants without any personal or familial history of HI was randomly recruited in Ghana, from an apparently healthy individual, during a tuberculosis screening study.

Molecular Methods {#s2_3}
-----------------

Peripheral blood was used for genomic DNA extraction, following the instructions on the manufacturer \[QIAamp DNA Blood Maxi Kit. ^®^ (Qiagen, USA)\], in the Laboratory of the Department of Biochemistry, University of Ghana, Accra, Ghana.

Previously reported, primers for the *GJB2* genes were evaluated using BLAST^®^ and and other Softwares as recommended ([@B5]). The entire coding region of *GJB2* genes (exon2) was amplified, followed by sequencing using an ABI 3130XL Genetic Analyzer^®^ (Applied Biosystems, Foster City, CA), in the Division of Human Genetics, University of Cape Town, South Africa.

Detection of del (*GJB6*-D13S1830) was performed using the method and primers described by del ([@B15]; [@B14]). The entire coding region of *GJB6* was amplified using the method described by ([@B9]). The PCR results were validated by Sanger sequencing of 10% of the sample.

Data Analysis {#s2_4}
-------------

Descriptive statistic and non-parametric test were used for comparisons. The level of significance was set at 5%.

Results {#s3}
=======

Sex, Age of Onset of Hearing Impairment {#s3_1}
---------------------------------------

A total of 1,104 participants was evaluated ([**Figure 1**](#f1){ref-type="fig"}). The male/female ratio was 1.49 (660/444). Most deaf participants (59.6%) had their first comprehensive HI medical test between the ages of 6 to 11 years ([**Table 1**](#T1){ref-type="table"} and [**Figure S1A**](#SM1){ref-type="supplementary-material"}). The median age of the students at the first medical diagnosis was 9.0 years, within a range of 2 to 22 years. The majority had pre-lingual HI (68.3%, *n* = 754; [**Figure S1B**](#SM1){ref-type="supplementary-material"}), of which 92.8% were congenital.

![Flowchart of the recruitment and Molecular analysis of Hearing Impairment cases in Ghana. *GJB2*-R143W mutation, previously reported as founder a mutation in Ghana accounted for 27.2% (22/81) of familial, and in 7.9% (11/140) of non-familial non-syndromic congenital HI cases.](fgene-10-00841-g001){#f1}

###### 

Age at diagnosis and onset of HI.

  Age of onset                          Number of cases, n (%)
  ------------------------------------- ------------------------
  Prelingual (before 2 years old)       754 (68.3%)
  Perilingual (between 2 and 4 years)   69 (6.3%)
  Post-lingual (after 4 years)          281 (25.5%)
  Total                                 1,104
  Age at first diagnosis                Number of cases, n (%)
  0--5                                  157 (14.2%)
  6--11                                 658 (59.6%)
  12--17                                258 (23.4%)
  18--23                                31 (2.8)
  Total                                 1,104

Audiometric Characterization of HI {#s3_2}
----------------------------------

Analysis of the students' medical data indicated that 642 out of the 1,104 students had a comprehensive HI test (otoscopic ear examination, pure tone audiometry, and/or tympanometry), which characteristics are described in [**Table S1**](#SM3){ref-type="supplementary-material"}. Nearly all the participants had sensorineural HI (99.5%; *n* = 639). Only 1 and 2 students had conductive and mixed HI, respectively.

Major Etiologies of Childhood HI in the Study Population {#s3_3}
--------------------------------------------------------

The flowchart of the cohort is described in [**Figure 1**](#f1){ref-type="fig"}, and the major cause of HI are displayed in [**Table 2**](#T2){ref-type="table"}. A lower frequency of infectious causes of HI was observed in our present study compared with other studies from sub-Saharan Africa ([**Table 2**](#T2){ref-type="table"}). Convulsion (with undetermined medical cause) was the most common cause of post-lingual HI followed by cerebrospinal meningitis (C.S.M.). Other diseases such as cerebral/complicated malaria, otitis media, and mumps, were also reported as causes of post-lingual HI ([**Figure S2**](#SM2){ref-type="supplementary-material"}). Over 60% of the students had congenital HI of unknown origin ([**Figure S2**](#SM2){ref-type="supplementary-material"}).

###### 

Comparison of our results to other studies in developing African countries.

  Country               The Gambia   Nigeria    Sierra Leone   Ghana     Cameroon   Present study
  --------------------- ------------ ---------- -------------- --------- ---------- ---------------
  Year of publication   1985         1982       1998           1988      2013       2018
  Reference             ([@B38])     ([@B22])   ([@B57])       ([@B6])   ([@B56])   
  Number of patients    259          298        354            105       582        1104
  Hereditary            8.1%         13.1%      --             --        14.8%      21.3%
  Meningitis            30%          11%        23.9%          8.5%      34.4%      3.9%
  Measles               1.9%         13%        4.1%           30%       4.3%       0.9%
  Rubella               1.5%         2%         --             3.8%      0.5%       0.2%
  Mumps                 --           3%         16.7%          3.5%      2.1%       0.5%
  Ototoxicity           --           9%         20.8%          --        6%         --
  Prematurity           --           --         --             --        0.9%       0.5%
  Neonatal jaundice     --           5.7%       --             1.9%      1.4%       0.3%
  Head trauma           --           --         --             --        0.3%       1.5%
  Other illnesses       --           --         --             --        --         10.8%
  Unspecified illness   --           --         --             --        --         6.3%
  Unknown               54.4%        41.2%      34.8%          40%       32.6%      53.8%

Familial HI With Possible Patterns of HI Inheritance {#s3_4}
----------------------------------------------------

We identified 97 families segregating hearing Impairment, in 21.4% of the students. In these families, 50.9% (235/461) of children were living with HI, with an average family size of 6.9. Most of these familial cases were non-syndromic (92/97). The pedigree analysis of the non-syndromic familial cases suggested autosomal recessive inheritance in 96.7% (89/92), with only 2 families exhibiting a pattern compatible with a non-syndromic autosomal dominant inheritance. One family exhibited a mitochondrial pattern of inheritance.

Waardenburg syndrome, an autosomal dominant condition, was the obvious syndromic and familial condition identified in 5.1% (5/97) of familial cases, with variable expression of heterochromia in affected members ([**Figure 2**](#f2){ref-type="fig"}).

![Probands with both Waardenburg syndrome, that associate variable degree of hearing impairment, and eyes/skin decoloration. Panels **(A)** and **(C)** represent patients expressing the typical bilateral striking blue eyes phenotype of Waardenburg syndrome, while **(B)** and **(D)** represent asymmetrical heterochromia, with patients expressing the phenotype in only one eye.](fgene-10-00841-g002){#f2}

Molecular Analysis Result of *GJB2* and *GJB6* {#s3_5}
----------------------------------------------

A total of 81 families segregating non-syndromic hearing loss were molecularly investigated. Although samples were not collected from Adamarobe, the 'Deaf village,' 27 out of the 81 HI families screened for *GJB2* and *GJB6* were from the Eastern Region of Ghana ([**Table S2**](#SM4){ref-type="supplementary-material"}) where the 'Deaf Village' is located ([@B30]).One individual from each family was sequenced for *GJB2* mutation and we found a pathogenic mutation in 27.2% (22/81) with *GJB2*- R143W in the majority (21/22) in the homozygous state ([**Table 3**](#T3){ref-type="table"}); *GJB2* p.W44\* mutation in one case, in the homozygous state.

###### 

*GJB2* mutations among 365 previously studied and 97 Ghanaians families with profound sensorineural hearing impairment.

  Nucleotide   Amino acid   Number of affected individuals                            
  ------------ ------------ -------------------------------- ------------ ----------- ----------
  35 insG      Frameshift   1(0.3%)                          --           --          --
  236T→C       L79P         1(0.3%)                          --           --          --
  427C→T       R143W        59 (16.2%)                       21 (25.9%)   11 (7.9%)   2 (1.4%)
  533T→C       V178A        2 (0.6%)                         --           --          --
  551G→A       R184Q        1(0.3%)                          --           --          --
  589G→T       A197S        1(0.3%)                          --           --          --
  608TC→AA     I203K        1(0.3%)                          --           --          --
  641T→C       L214P        1(0.3%)                          --           --          --
  131G \> A    W44\*        --                               1 (1.2%)     --          --

In non-familial non-syndromic cases, *GJB2*-R143W mutation was found in 7.9% (11/140) patients ([**Figure 1**](#f1){ref-type="fig"}). The control population had 2 out of the 145 individuals with mutation *GJB2*-R143W in the heterozygous state.

No *GJB6*-D3S1830 deletion was identified in the samples screened.

Discussion {#s4}
==========

The present report in the most compressive study of the cause of childhood HI in Ghana. Moreover, we investigated for the first time, the prevalence of *GJB2* mutations in a non-affected group of individuals from Ghana.

In this study, we observed HI in more boys than girls, although gender has not been reported as an associated factor that predisposes children to the development of HI ([@B17]; [@B32]). This may be due to the fact that more boys enroll in the schools for the deaf compared to girls, especially in resource-limited regions. In often cases, boys with disability have more priority to formal education compared to girls ([@B19]; [@B40]; [@B45]). Although "female protective model" is not common to HI studies, it has been proposed by some researchers to explain the higher prevalence of genetic disorders in males compared to females ([@B23]; [@B53]). According to this model, females have a higher rate of possible gene disruption but are mostly not associated with genetic disorders compared to males ([@B23]).

Hearing impairment screening aims at detecting permanent HI at early developmental ages for the appropriate intervention ([@B47]; [@B11]; [@B36]). There is no universal newborn HI screening program in Ghana explaining the late diagnosis, as most of the study participants had their first comprehensive hearing test at the school age, thus 6--9 years of age. However, parents/guardians of these children gave the information on the onset of the condition. The late diagnostic of HI in Ghanaian children is partly tied to the limited number of hearing assessment facilities ([@B52]). In addition, the majority of the HI students were living in remote rural settlements often with unmemorable roads and hence the difficulty of having access to quality health care.

Post-lingual HI in Africa is often caused by environmental factors ([@B56]). Similar to other reports, complicated malaria, cerebrospinal meningitis, and convulsion (with undetermined cause) were identified from our study as major environmental factors that contribute to post-lingual HI in Ghana ([**Table 2**](#T2){ref-type="table"}). There was a high number of congenital cases reported in our study which may account for the reduced frequency of infectious causes of HI in our study compared to other studies from Africa. Nonetheless, the identified environmental factors can be prevented by good health care systems as well as preventive health care practices. It is therefore important that governmental policies should be implemented to minimize childhood morbidities which will eventually reduce the prevalence of post-lingual HI.

Pre-lingual hearing impairment was common in our study population which agrees with other findings ([@B10]). Majority of pre-lingual HI are congenital and are usually caused by genetic factors ([@B56]; [@B4]). Waardenburg syndrome was the most common syndromic HI identified among the congenital cases in line with other African data ([@B42]).

Mutations in *GJB2* were investigated in Ghana 18 years ago and identified a common founder mutation p.R143W ([@B20]). The present study revisited the contribution of *GJB2* mutations and confirm the particularly high proposition of the founder mutation in more than ¼ of families segregating HI. This is much higher than what was previously reported (18%) due to the stringent selection of familial cases in the present study. Majority of the families with HI and families positive for the founder mutation were from the Eastern Region of Ghana. It is from this Region that a high prevalence of congenital HI was reported and hence the name "Deaf Village" ([@B13]; [@B30]). There was a relatively high proportion of *GJB2* mutations among the isolated case of putative genetics origin. This is an indication of the urgent need to implement this *GJB2*-p.R143W testing in patients with HI clinical practice in Ghana. The p.R143W mutation has also been reported in patients with HI in Japan ([@B59]; [@B28]), South Korea ([@B29]), and China ([@B35]). In addition, we report a variant previously described as Mayan: founder *GJB2* nonsense mutation (p.W44\*) in a Ghanaian family. *GJB2* p.W44\* mutation is the most common *GJB2* pathogenic variant in Guatemala deaf populations and was also reported in Mexico ([@B37]). Ghana is an African exception, as most studies in Africa have not identify *GJB2* as a major cause of HI in sub-Saharan African populations ([@B33]; [@B54]).

This is the first study to investigate *GJB6*-D13S1830 mutation or coding region variations in Ghana, and we found no mutation, which is in line with previous African data ([@B5]; [@B55]). Equally, *GJB6*-D13S1830 deletion was not found in populations from China ([@B26]), India ([@B44]), Turkey ([@B50]), and among African American and Caribbean Hispanics ([@B46]). Therefore, the present data further support the hypothesis that the *GJB6*-D13S1830 deletion is a founder mutation ([@B14]).

The study also indicates more than 2/3 of families with HI are eligible for next-generation sequencing, due to the highly heterogeneous genetic nature of NSHI and the low proportion of families solved with single gene approach applied in this study. Nethetheless, the study did not exclude intronic variants in *GJB2*, that is a possible limitation. Future research should either use high-throughput sequencing platforms to investigate known genes ([@B48]; [@B34]), or whole exome sequencing that will allow identification of novel genes ([@B16]). Indeed, based on the identification of specific inner ear transcripts, it is estimated that more than 1,000 NSHI genes are still to be identified ([@B21]).

To contribute towards the reduction of HI incidence in Ghana, policy-makers must consider integrating newborn screening for HI into the health care system such that every child is screened for both genetic and acquired HI at birth. Early detection of the condition may lead to early intervention ([@B12]) which will eventually reduce the public health impact of this condition.

Conclusion {#s5}
==========

The study showed that environmental factors remain a major cause of Hearing impairment in Ghana. The study confirms that Connexin 26 (*GJB2*) mutations are the most common cause of familial non-syndromic HI in Ghana, an exception in sub-Saharan Africa where mutations in *GJB2* in HI patients is generally close to zero. *GJB2* p.R143W founder mutation accounted more \> 25% of familial cases and close to 8% of isolated cases of putative genetic origin and should be considered in for implementation in clinical practice, particularly after newborns screening for HI. The frequency of *GJB2* p.R143W founder mutation in the general population without personal and familial was relatively high: 1.4%. The study did not find any *GJB6* del(GJB6-D13S1830) deletion. Future studies should employ whole genome sequencing approaches and functional genomics studies to identify the other genes involved in most families, and in isolated cases of HI in Ghana.
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###### 

Onset and time of HI test. **(A)** Age of deaf students at the first medical HI test. **(B)** Onset of HI. Paired T-test was used to compare the mean number of students with pre-lingual (n = 754) and post-lingual (n = 336) HI from 11 schools for the deaf. There was a significant difference between mean number of people with pre- and post-lingual HI with P value of 0.0001 (t = 7.68, df = 10).
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Click here for additional data file.

###### 

Major causes of childhood HI in Ghana. **(A)** Major causes of post-lingual HI in Ghana. **(B)** Major causes of Pre-lingual HI in Ghana. Cerebrospinal meningitis was represented as C.S.M. The cause of HI labelled accident comprises of motor accidents and medical accidents such as wrong medication, child birth, and surgery. Diseases such as boil, anemia, Gilbertese, Jaundice, measles, mumps, Otitis media, and rubella were captured as other diseases while undefined sickness consist of individuals who developed the condition due to sickness, but the cause of the sickness was not determined.
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Click here for additional data file.
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Click here for additional data file.
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